Latest News about GILD
Recent news which mentions GILD
Better Buy: Gilead Sciences vs. Pfizer
Today 6:12 EST
From Motley Fool
Could Sorrento Therapeutics Be a Millionaire-Maker Stock?
November 22, 2020
From Motley Fool
This Company's New Approach Could Slash Gilead's Profit From HIV Drugs
November 22, 2020
From Motley Fool
Is There Room for Latecomers to the COVID-19 Party?
November 21, 2020
From Motley Fool
WHO Recommends Against Using Gilead's Remdesivir for COVID-19
November 20, 2020
Tickers
GILD
From Motley Fool
Pharma Sector Did Its Job With COVID-19 Vaccine: Barclays Analyst
November 20, 2020
From Benzinga
Coronavirus update: U.S. moves closer to 200,000 cases a day; Birx and Fauci urge Americans to follow safety measures over Thanksgiving
November 20, 2020
From MarketWatch
The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger
November 20, 2020
From Benzinga
Stock-index futures mixed as COVID restrictions threaten recovery
November 20, 2020
From MarketWatch
Is Sorrento Therapeutics Stock a Buy?
November 20, 2020
From Motley Fool
A Peek Into The Markets: US Stock Futures Slightly Lower Ahead Of Earnings, Fed Speakers
November 20, 2020
From Benzinga
European stocks inch up, while U.S. futures fall on virus headlines and spending spat between Fed and Treasury
November 20, 2020
Tickers
GILD
From MarketWatch
From Benzinga
From Benzinga
WHO advisers recommend against Gilead’s remdesivir for treating COVID-19
November 19, 2020
Tickers
GILD
Tags
GILD
From MarketWatch
Sorrento CEO Henry Ji on How the Company Got Its Start
November 19, 2020
From Motley Fool
Is Moderna Still a Compelling Growth Play?
November 18, 2020
From Motley Fool
From MarketWatch
From Benzinga
The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts
October 30, 2020
From Benzinga
From MarketWatch
Stocks That Hit 52-Week Lows On Thursday
October 29, 2020
From Benzinga
10 Biggest Price Target Changes For Thursday
October 29, 2020
From Benzinga
The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal
October 29, 2020
From Benzinga
Stock futures rise ahead of GDP data after worst day since June
October 29, 2020
From MarketWatch
Fast start for coronavirus drug boosts Gilead earnings, sends stock higher in late trading
October 28, 2020
From MarketWatch
Stocks That Hit 52-Week Lows On Wednesday
October 28, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.